HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yu-Ching Lee Selected Research

Estrogen Receptors

1/2019Mitochondrial translocation of estrogen receptor β affords resistance to oxidative insult-induced apoptosis and contributes to the pathogenesis of endometriosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yu-Ching Lee Research Topics

Disease

26Neoplasms (Cancer)
02/2024 - 01/2010
6Snake Bites (Snake Bite)
11/2020 - 05/2015
5Ovarian Epithelial Carcinoma
11/2023 - 01/2022
5Ovarian Neoplasms (Ovarian Cancer)
01/2023 - 01/2022
4Breast Neoplasms (Breast Cancer)
03/2023 - 01/2022
4Hyperpigmentation
07/2015 - 11/2014
3Stroke (Strokes)
02/2024 - 01/2021
3Papillary Carcinoma
01/2023 - 01/2022
3Neurodegenerative Diseases (Neurodegenerative Disease)
07/2015 - 11/2014
2Pancreatic Neoplasms (Pancreatic Cancer)
12/2023 - 11/2023
2Stomach Neoplasms (Stomach Cancer)
12/2023 - 11/2023
2Disease Progression
11/2023 - 03/2022
2Carcinoma (Carcinomatosis)
03/2023 - 01/2022
2Leukemia
10/2019 - 01/2017
1Microsatellite Instability
11/2023
1Carcinogenesis
11/2023
1Pathologic Neovascularization
01/2023
1Prostatic Neoplasms (Prostate Cancer)
01/2022
1Virus Diseases (Viral Diseases)
12/2021
1COVID-19
01/2021
1Invasive Candidiasis
04/2020
1Neoplasm Metastasis (Metastasis)
12/2019
1Meningitis
07/2019
1Female Infertility
01/2019
1Endometriosis
01/2019
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2018
1Thyroid Neoplasms (Thyroid Cancer)
01/2018
1Mitochondrial Diseases (Mitochondrial Disease)
01/2018
1Hepatocellular Carcinoma (Hepatoma)
01/2017
1Body Weight (Weight, Body)
01/2017
1Wounds and Injuries (Trauma)
12/2016
1Malaria
01/2016
1Weight Loss (Weight Reduction)
01/2016
1Glucose Intolerance
01/2016

Drug/Important Bio-Agent (IBA)

8Therapeutic UsesIBA
11/2023 - 01/2020
7AntibodiesIBA
11/2023 - 10/2010
6Biomarkers (Surrogate Marker)IBA
01/2023 - 12/2019
6Proteins (Proteins, Gene)FDA Link
01/2023 - 10/2010
5Bevacizumab (Avastin)FDA Link
11/2023 - 01/2022
4Monoclonal AntibodiesIBA
01/2023 - 01/2020
4Melanins (Melanin)IBA
07/2015 - 11/2014
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023 - 11/2020
3Single-Chain AntibodiesIBA
01/2023 - 12/2016
3Antivenins (Antivenoms)IBA
11/2020 - 12/2016
3Monophenol Monooxygenase (Tyrosinase)IBA
02/2015 - 11/2014
2Peptides (Polypeptides)IBA
02/2024 - 01/2010
2Immunoglobulin FragmentsIBA
12/2023 - 11/2023
2Immunoglobulin G (IgG)IBA
11/2023 - 01/2013
2EpitopesIBA
11/2023 - 10/2015
2Tumor Biomarkers (Tumor Markers)IBA
11/2023 - 01/2023
2Hematoxylin (Haematoxylon)IBA
01/2022 - 01/2022
2Eosine Yellowish-(YS) (Eosin)IBA
01/2022 - 01/2022
2Neutralizing AntibodiesIBA
01/2021 - 10/2015
2Phosphopyruvate Hydratase (Enolase)IBA
04/2020 - 10/2010
2IgYIBA
12/2016 - 10/2010
2EnzymesIBA
02/2015 - 11/2014
2CopperIBA
02/2015 - 11/2014
2CosmeticsIBA
02/2015 - 11/2014
1Immunoconjugates (Immunoconjugate)IBA
12/2023
1AntigensIBA
12/2023
1auristatinIBA
12/2023
1monomethyl auristatin EIBA
12/2023
1Trastuzumab (Herceptin)FDA Link
11/2023
1Vascular Endothelial Growth FactorsIBA
11/2023
1GemcitabineFDA Link
11/2023
1ErythropoietinFDA Link
11/2023
1Ephrin-A1 (Ephrin A1)IBA
11/2023
1crassolideIBA
03/2023
1Cell Adhesion MoleculesIBA
03/2023
1Mitogen-Activated Protein Kinase 14IBA
03/2023
1Immune Checkpoint ProteinsIBA
03/2023
1Angiopoietin-2IBA
01/2023
1Protein Isoforms (Isoforms)IBA
01/2023
1human ERBB2 proteinIBA
01/2023
1Pyruvate KinaseIBA
01/2023
1ParaffinIBA
01/2023
1Epidermal Growth Factor (EGF)IBA
03/2021
1B7-H1 AntigenIBA
01/2020
1CateninsIBA
12/2019
1OMPA outer membrane proteinsIBA
07/2019
1Estrogens (Estrogen)FDA Link
01/2019
1Estrogen ReceptorsIBA
01/2019
1Selective Estrogen Receptor Modulators (SERM)IBA
01/2019
1MPT0L145IBA
01/2018
1Cisplatin (Platino)FDA LinkGeneric
01/2018
1VenomsIBA
10/2017
1Anti-Arrhythmia AgentsIBA
01/2017
1lanatoside CIBA
01/2017
1Protein Kinases (Protein Kinase)IBA
01/2017
1Digoxin (Digitek)FDA LinkGeneric
01/2017
11-benzylindoleIBA
01/2017
1Cardiac GlycosidesIBA
01/2017
1Antimalarials (Antimalarial Agents)IBA
01/2016
1Glucose (Dextrose)FDA LinkGeneric
01/2016

Therapy/Procedure

12Therapeutics
02/2024 - 05/2007
5Immunotherapy
02/2024 - 12/2019
4Drug Therapy (Chemotherapy)
01/2023 - 01/2016
3Thrombectomy
02/2024 - 01/2021
2Aftercare (After-Treatment)
11/2023 - 03/2022
2Precision Medicine
01/2023 - 01/2018